Beyond receptor expression levels: The relevance of target accessibility in ligand-directed pharmacodelivery systems

被引:37
|
作者
Ozawa, Michael G.
Zurita, Amado J.
Dias-Neto, Emmanuel
Nunes, Diana N.
Sidman, Richard L. [3 ,4 ]
Gelovani, Juri G. [2 ]
Arap, Wadih [1 ]
Pasqualini, Renata [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Expt Diagnost Imaging, Houston, TX 77030 USA
[3] Harvard Univ, Sch Med, Boston, MA 02115 USA
[4] Harvard Univ, Inst Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/j.tcm.2008.03.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
For development of a new ligand-directed pharmacology, it is critical to measure delivery of targeted drug ligands via molecular imaging or diagnostic readouts (termed theranostics). Combinatorial peptide libraries serve as unbiased functional screens that can identify specific peptides targeting cell-surface receptors accessible to the circulation. As candidate drug leads, such peptides provide motifs likely to modify ligand-receptor interactions and downstream signal transduction pathways. This strategy is synergistic with genomic and proteomic approaches and has yielded insights into the specialized nature of the target tissue microenvironment. However, for this vision to be realized, one must look, as recent literature suggests, beyond receptor levels and critically analyze ligand accessibility as a key determinant in pharmacodelivery systems.
引用
收藏
页码:126 / 133
页数:8
相关论文
共 50 条
  • [31] A novel bispecific ligand-directed toxin designed to simultaneously target EGFR on human glioblastoma cells and uPAR on tumor neovasculature
    Tsai, Alexander K.
    Oh, Seunguk
    Chen, Hua
    Shu, Yanqun
    Ohlfest, John R.
    Vallera, Daniel A.
    JOURNAL OF NEURO-ONCOLOGY, 2011, 103 (02) : 255 - 266
  • [32] Platform Reagents Enable Synthesis of Ligand-Directed Covalent Probes: Study of Cannabinoid Receptor 2 in Live Cells
    Kosar, Miroslav
    Sykes, David A.
    Viray, Alexander E. G.
    Vitale, Rosa Maria
    Sarott, Roman C.
    Ganzoni, Rudolf L.
    Onion, David
    Tobias, Janelle M.
    Leippe, Philipp
    Ullmer, Christoph
    Zirwes, Elisabeth A.
    Guba, Wolfgang
    Grether, Uwe
    Frank, James A.
    Veprintsev, Dmitry B.
    Carreira, Erick M.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2023, 145 (28) : 15094 - 15108
  • [33] A novel bispecific ligand-directed toxin designed to simultaneously target EGFR on human glioblastoma cells and uPAR on tumor neovasculature
    Alexander K. Tsai
    Seunguk Oh
    Hua Chen
    Yanqun Shu
    John R. Ohlfest
    Daniel A. Vallera
    Journal of Neuro-Oncology, 2011, 103 : 255 - 266
  • [34] Ligand-directed c-Jun N-terminal kinase activation disrupts opioid receptor signaling
    Melief, Erica J.
    Miyatake, Mayumi
    Bruchas, Michael R.
    Chavkin, Charles
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (25) : 11608 - 11613
  • [35] Molecular and chemical aspects of the histamine receptors -: Molecular determinants of ligand-directed signaling for the histamine H1 receptor
    Booth, R. G.
    Fang, L.
    Wilczynski, A.
    Sivendren, S.
    Sun, Z.
    Travers, S.
    Bruysters, M.
    Sansuk, K.
    Leurs, R.
    INFLAMMATION RESEARCH, 2008, 57 (Suppl 1) : S43 - S44
  • [36] Ligand-directed tosyl chemistry for in situ native protein labeling and engineering in living systems: from basic properties to applications
    Tsukiji, Shinya
    Hamachi, Itaru
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2014, 21 : 136 - 143
  • [37] Ligand-Directed Reduction-Sensitive Shell-Sheddable Biodegradable Micelles Actively Deliver Doxorubicin into the Nuclei of Target Cancer Cells
    Zhong, Yinan
    Yang, Weijing
    Sun, Huanli
    Cheng, Ru
    Meng, Fenghua
    Deng, Chao
    Zhong, Zhiyuan
    BIOMACROMOLECULES, 2013, 14 (10) : 3723 - 3730
  • [38] The myosuppressin structure-activity relationship for cardiac contractility and its receptor interactions support the presence of a ligand-directed signaling pathway in heart
    Nichols, R.
    Pittala, K.
    Leander, M.
    Maynard, B.
    Nikolaou, P.
    Marciniak, P.
    PEPTIDES, 2021, 146
  • [39] Secretin Receptor as a Target in Gastrointestinal Cancer: Expression Analysis and Ligand Development
    Klussmeier, Anja
    Aurich, Stefan
    Niederstadt, Lars
    Wiedenmann, Bertram
    Groetzinger, Carsten
    BIOMEDICINES, 2022, 10 (03)
  • [40] Targeting IL11 Receptor in Leukemia and Lymphoma: A Functional Ligand-Directed Study and Hematopathology Analysis of Patient-Derived Specimens
    Karjalainen, Katja
    Jaalouk, Diana E.
    Bueso-Ramos, Carlos
    Bover, Laura
    Sun, Yan
    Kuniyasu, Akihiko
    Driessen, Wouter H. P.
    Cardo-Vila, Marina
    Rietz, Cecilia
    Zurita, Amado J.
    O'Brien, Susan
    Kantarjian, Hagop M.
    Cortes, Jorge E.
    Calin, George A.
    Koivunen, Erkki
    Arap, Wadih
    Pasqualini, Renata
    CLINICAL CANCER RESEARCH, 2015, 21 (13) : 3041 - 3051